Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injectable Atropine and Epinephrine for Pupil Dilation in Phacoemulsification
NCT03638726Phase 4Unknown
- Sponsor
- Dar El Oyoun Hospital
- Start
- Sep 2018
- Primary completion
- Mar 2019
- Modality
- Orthosteric Ligands, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 4 trial of atropine, epinephrine nasal spray in cataract, sponsored by Dar El Oyoun Hospital. Status: unknown.
02
Drugs
atropineepinephrine nasal spray
03
Conditions
cataract
Beyond the preview
Go deeper on NCT03638726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03638726.